Hypoglycemia: from the laboratory to the clinic.
Amiel
Stephanie A
SA
D001364:Awareness / Q000187:drug effects / Q000502:physiology*; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism; D003072:Cognition Disorders / Q000209:etiology*; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology*; D004837:Epinephrine / Q000627:therapeutic use; D019788:Fluorodeoxyglucose F18; D006321:Heart / Q000503:physiopathology*; D006706:Homeostasis; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000523:psychology*; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use; D011877:Radionuclide Imaging; D012016:Reference Values
D007004:Hypoglycemic Agents; D007328:Insulin; D019788:Fluorodeoxyglucose F18; D004837:Epinephrine